Chicago Research Center, Inc.

Chicago Research Center, Inc. Clinical Trial Center Chicago Research Center, Inc. People participate in clinical research for a variety of reasons. This care also may be free.

is a privately owned and operated investigational site specializing in phase II, III and IV clinical trials for the pharmaceutical and biotechnology industries. CRC operates as an independent research center solely dedicated to conducting clinical trials in a broad array of specialties; including psychiatric, general medicine and sleep.

“Our approach is uncompromising; we exceed sponsor expectations for reliability and dependability, subject enrollment, human protection and overall performance.” -Stacy Malm, President

Before a new medication can be prescribed or sold over the counter it must be approved by the Food and Drug Administration or FDA. In order for the FDA to approve a medication, the pharmaceutical company must show that the medication is both safe and effective for use in the treatment for which it is intended. To show this efficacy and safety the pharmaceutical company will spend many years conducting a series of studies. The clinical testing of experimental drugs is normally done in three phases, each successive phase involving a larger number of people. Once the FDA has granted a New Drug Approval (NDA), pharmaceutical companies also conduct post marketing or late phase three/phase four studies. People who volunteer for phase II and phase III trials can gain access to promising drugs long before these compounds are approved for the marketplace. They typically will get excellent care from the physicians during the course of the study. The patient's rights and safety are protected in two important ways. First, any physician awarded a research grant by a pharmaceutical company or the NIH must obtain approval to conduct the study from an Institutional Review Board. The review board, which is usually composed of physicians and lay people, is charged with examining the study's protocol to ensure that the patient's rights are protected, and that the study does not present an undue or unnecessary risk to the patient. Second, anyone participating in a clinical trial in the United States is required to sign an "informed consent" form. This form details the nature of the study, the risks involved, and what may happen to a patient in the study. The informed consent tells patients that they have a right to leave the study at any time. Patients considering participating in clinical research should talk about it with their physicians and medical caregivers. They also should seek to understand the credentials and experience of the individuals and the facility involved in conducting the study.

www.koastalstudy.com
03/26/2024

www.koastalstudy.com

During KOASTAL, you will receive all study-related care from a dedicated medical team at no cost. Reimbursement for study-related expenses may be available to you

CRC is excited to announce the enrollment of a research study! Completely remote , can be done from the comfort of ...
03/02/2021

CRC is excited to announce the enrollment of a research study! Completely remote , can be done from the comfort of your own home using only your smartphone! Help us test an investigational app to see if it will aid in treating symptoms of depression! Compensation up to $350 for qualified candidates.
Sign-Up via the link: https://www.projectbaseline.com/studies/mirai-depression/
Once you verify your identity, all you have to do is hang tight until one of our clinicians reaches out to confirm your eligibility, and schedule your screening call!

At-home depression study using your phone

https://www.jnj.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints-in-in...
02/02/2021

https://www.jnj.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial
The light at the end of the tunnel is shining brighter each day! We are grateful to have been a part of multiple clinical trials for Johnson & Johnson in the past. Currently, we are accepting volunteers for Janssen's (of Johnson & Johnson) Esketamine research study!

Vaccine Candidate 72% Effective in the US and 66% Effective Overall at Preventing Moderate to Severe COVID-19, 28 Days after Vaccination85% Effective Overall in Preventing Severe Disease and Demonstrated Complete Protection Against COVID-19 related Hospitalization and Death as of Day 28Protection Ag...

Not feeling yourself? Take back control over your emotions by enrolling in one CRC's many ! Receive up to 10-months w...
02/02/2021

Not feeling yourself? Take back control over your emotions by enrolling in one CRC's many ! Receive up to 10-months worth of FREE mental health care, no insurance required! We are working with both FDA-approved and on the market treatments, as well as novel treatments.
Compensation up to $1900, free transportation assistance may be available to/from visits.
Find the right treatment for you, sign up via the link: www.ChicagoResearchCenter.com/contact-us/

12/30/2020
As the global health situation is continuing to appear out of control, your mental health shouldn't be. It is now more d...
11/25/2020

As the global health situation is continuing to appear out of control, your mental health shouldn't be. It is now more difficult than ever to access mental health care due to potential loss of insurance and incomes. Chicago Research Center is here to make your mental health our priority. CRC is now enrolling for multiple Depression research studies that provides access to ground-breaking Depression treatment at no cost to you, no insurance required. Sign-up to see if you qualify for one of our clinical trials: www.ChicagoResearchCenter.com/contact-us/

Chicago Research Center remains OPEN and ESSENTIAL. We are all in this together, and CRC is taking the necessary precautions during this time to ensure the safety of patients and staff. Your wellbeing takes precedence.

https://wgntv.com/news/coronavirus/illinois-health-officials-report-9469-new-cases-of-covid-19-125-deaths/

CHICAGO (AP) — State health officials reported on Tuesday that another 125 people in Illinois have died from COVID-19. In a news release, the Illinois Department of Public Health said the latest de…

Address

3401 N Central Avenue
Chicago, IL
60634

Opening Hours

Monday 8am - 6pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 8am - 3pm

Telephone

(773) 282-9845

Website

Alerts

Be the first to know and let us send you an email when Chicago Research Center, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Chicago Research Center, Inc.:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category